Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate and Ranibizumab ophthalmic
Determining the interaction of Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / phenylephrine / potassium guaiacolsulfonate
Brand name:
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Capsule
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Hydrochloride
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Injection
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Suspension
- Phenylephrine, Carbetapentane, Potassium Guaiacolsulfonate-Ranitidine Syrup
- Ranibizumab ophthalmic-Phenylephrine, Chlorpheniramine, and Carbetapentane Liquid
- Ranibizumab ophthalmic-Phenylephrine, Chlorpheniramine, and Chlophedianol Suspension
- Ranibizumab ophthalmic-Phenylephrine, Chlorpheniramine, and Codeine Syrup
- Ranibizumab ophthalmic-Phenylephrine, Dexchlorpheniramine, and Codeine
- Ranibizumab ophthalmic-Phenylephrine, Pyrilamine, and Chlophedianol Liquid
- Ranibizumab ophthalmic-Phenylephrine, Thonzylamine, and Dextromethorphan Liquid